#3dbioprinting

[vexmatech]

#vexmasoup : Engineering New Materials in Medical 3D Printing 

 cc : ASME American Society of Mechanical Engineers

[apurvarahate]

Human Liver Model Market: Growth, Innovations, and the Future of Biomedical Research

In recent years, the Human Liver Model Market has emerged as one of the most promising areas in biomedical research. As pharmaceutical companies and research institutions continue to look for alternatives to animal testing, human liver models—which replicate the structure and function of the human liver—are transforming how we study diseases, evaluate drug toxicity, and understand liver physiology.

The human liver mode market size was estimated at USD 1.21 billion in 2023 and it is expected to surpass around USD 4.42 billion by 2033, at

What Are Human Liver Models?

Human liver models are advanced biological systems designed to mimic the real functions of the human liver. These models can be 2D cell cultures, 3D organoids, or bioengineered tissue platforms, allowing scientists to study liver diseases, metabolism, and drug-induced liver injury more accurately than ever before.

Applications Transforming Healthcare

Drug Discovery & Development: Enables faster and more reliable testing of new compounds.

Disease Modeling: Helps simulate liver disorders like hepatitis, fibrosis, and fatty liver disease.

Regenerative Medicine: Supports liver tissue engineering and transplantation research.

[lifesciencesmagazine]

Revolutionizing Diabetes Treatment with 3D Bioprinting Technology

Source: irishpharmacist.ie

A Breakthrough in Diabetes Research

A research team at Pohang University of Science and Technology (POSTECH), led by Professor Jinah Jang, has developed an innovative platform for diabetes treatment using 3D bioprinting technology. Alongside Ph.D. candidate Myungji Kim from the Division of Interdisciplinary Bioscience and Bioengineering, the team successfully created a bioink derived from pancreatic tissue, paving the way for more effective therapies.

Diabetes is a complex metabolic disorder caused by dysfunction in the pancreas, an organ responsible for maintaining blood sugar levels. Within the pancreas, islet cells play a crucial role in insulin secretion, but generating these cells for therapeutic purposes has remained a significant challenge. While stem cells provide a potential solution, replicating the exact environment necessary for their function—particularly the extracellular matrix (ECM) and vascular support—has been a major roadblock.

3D Bioprinting to Mimic the Human Pancreas

The POSTECH research team addressed this challenge by developing a specialized bioink called PINE (Peri-islet Niche-like ECM), which contains key components such as laminin and collagen IV, extracted from pancreatic tissue. Using advanced 3D bioprinting technology, they fabricated the Human Islet-like Cellular Aggregates and Vasculature (HICA-V) platform.

This platform accurately arranges stem cell-derived islet cells alongside vascular structures, replicating the architecture of a functional pancreas. When cultured in the HICA-V platform, islet cells demonstrated enhanced insulin production and improved protein binding, closely resembling the behavior of native pancreatic islets.

Moreover, the platform successfully simulated diabetic conditions by triggering inflammatory gene responses, making it a valuable tool for both research and drug development. By faithfully replicating the pancreatic microenvironment, the HICA-V platform enhances the maturation and function of stem cell-derived islets, offering new hope for diabetes treatment.

Transforming Diabetes Treatment and Drug Development

Professor Jinah Jang emphasized the significance of this development, stating, “The customized pancreatic islet platform created through this research effectively replicates the human endocrine pancreas, supporting the maturation and functionality of stem cell-derived islets.” She further highlighted its potential to advance diabetes research, accelerate the development of anti-diabetic drugs, and improve islet transplantation therapies.

The research received funding from multiple South Korean institutions, including the National Research Foundation of South Korea (NRF), the Ministry of Science and ICT, the Korean Fund for Regenerative Medicine, and the Alchemist Project under the Ministry of Trade, Industry, and Energy.

This pioneering work represents a major step forward in diabetes treatment. By utilizing 3D Bioprinting technology to replicate pancreatic function, the research not only provides a new model for studying diabetes but also offers promising avenues for developing more effective treatments and therapies in the future.

[metastatblog]

3D Bioprinting Market Analysis, Size, Share, Growth, Trends, and Forecasts by 2031

The Global 3D Bioprinting market and its industry will be the new landmark of modern healthcare and regenerative medicine. This market, with advancing technology, is going to reshape the future of medical research, tissue engineering, and drug development. Using 3D printing technology, this process allows for layer by layer creation of biological tissues, opening doors to unprecedented medical treatments and innovations. 

𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.metastatinsight.com/request-sample/3176

Companies

Organovo Holdings, Inc.

CELLINK AB

EnvisionTEC GmbH

3D Systems, Inc.

Allevi Inc.

Regemat 3D S.L.

Merck KGaA

Cyfuse Biomedical K.K.

Sunp Biotech

RegenHU Ltd.

Voxcell Bioinnovation Inc.

Poietis

Advanced Solutions Life Sciences

GeSiM (Gesellschaft für Silizium-Mikrosysteme mbH)

Inventia Life Science Pty Ltd

T𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:@https://www.metastatinsight.com/report/3d-bioprinting-market

Near-term, Global 3D Bioprinting Market will see further development of its first applications in the research and pharmaceutical industries. Newer technologies of bioinks, cellular materials, and higher software will come into market for raising degrees of precision for tissue modeling and drug testing. It will come with meaningful developments in generating patient-specific treatments and designed therapies, along with complexities in tissue structure for the implants. 

The Global 3D Bioprinting market will also feel the shifts in the regulatory landscape. With bioprinted tissues and organs now entering widespread use in medicine, regulatory bodies will only streamline their rules and requirements so that such treatments don’t harm and are found effective. This will boost even more confidence in such solutions from the medical profession to the patient’s hands. A successful framework for bioprinted medical solutions will be built in partnership between providers, research organizations, and regulators. 

Educational institutions and research organizations will be the source of innovation for the Global 3D Bioprinting market. More people will be trained with the knowledge of bioprinting technologies and applications as the knowledge base continues to grow. This would ensure that the workforce was qualified to develop, operate, and improve bioprinting technologies. Besides, this partnership between the academic institutes and the private companies would encourage a place where ideas can be translated into marketable solutions with rapidity. 

The Global 3D Bioprinting market and industry are set to experience quite tremendous growth. With every step of advancement in the bioprinting technology, the scope of application will expand, thereby entering into healthcare, research, and even environmental sectors. The developments within this market will undoubtedly transform industries in the future, unlocking through 3D bioprinting the keys that can solve some of the world’s most challenging medical and environmental challenges. 

Global 3D Bioprinting market is estimated to reach $2,813.40 Million by 2031; growing at a CAGR of 12.7% from 2024 to 2031.

Contact Us:   

[email protected]

[phone]

[amrtechinsights]

3D Bioprinting in Ophthalmology

Explore the advancements of 3D bioprinting in ophthalmology, transforming eye care and offering innovative treatments for vision restoration

Revolutionizing eye care with 3D bioprinting! 👁️✨ Unlocking new possibilities in vision restoration, prosthetics, and more. The future of ophthalmology is here! 🔬🚀 #3DBioprinting #Ophthalmology #InnovativeHealthcare #VisionRestoration #MedicalTechnology #Bioprinting #FutureOfMedicine #HealthTech

[yashmedica]

From Microextrusion to Magnetic: Exploring the Latest 3D Bioprinting Technologies

3D Bioprinting Revolution: Printing Human Tissues in 2024! (CELLINK, EnvisionTEC) Explore top technologies, bioinks & latest advancements shaping the future of bioprinting & regenerative medicine

3D Bioprinting: A Printing Revolution for Human Tissues (2024 Update) 3D bioprinting has the potential to revolutionize healthcare by generating functional human tissues and organs. This article investigates significant 3D bioprinting technologies, recent advancements, and the effect of the best companies in 2024. Which 3D Bioprinting Technologies are Leading the Way? Several 3D bioprinting…

View On WordPress

[yashmedica]

Stryker to Organovo: Leading Players Shaping the Future of Tissue Engineering

Tissue Engineering Market (2024): See how Stryker, Organovo & others are driving growth with 3D bioprinting & gene editing, shaping the future of healthcare

Tissue Engineering Market: A Breakdown by Application (2024) The field of tissue engineering is rapidly evolving, offering promising solutions for regenerating damaged tissues and organs. This study explores into the market’s application segments, looking at important trends, technologies, and the effect of the top companies in 2024. Which application segment is leading the Tissue Engineering…

View On WordPress

[yashmedica]

Bioprinting in Tissue Engineering: A Game-Changer for Organ Regeneration (March 2024 Update)

The booming Tissue Engineering Market, revolutionizing regenerative medicine with bioprinting! Explore market analysis, top companies, and innovations transforming how we repair and replace damaged tissues

Tissue Engineering Market: Revolutionizing Regenerative Medicine The tissue engineering market is experiencing a surge in growth, driven by the increasing demand for innovative solutions in regenerative medicine. This field holds immense potential for treating a wide range of conditions by creating functional tissues that can repair, replace, or restore damaged ones. Traditionally, organ…

View On WordPress